FDA Approval Summary: Nivolumab for the Adjuvant Treatment of Adults with Completely Resected Esophageal/Gastroesophageal Junction Cancer and Residual Pathologic Disease.

Horiba, M Naomi; Casak, Sandra J; Mishra-Kalyani, Pallavi S; Roy, Pourab; Beaver, Julia A; Pazdur, Richard; Kluetz, Paul G; Lemery, Steven J; Fashoyin-Aje, Lola A

Horiba, M Naomi; Casak, Sandra J; Mishra-Kalyani, Pallavi S; Roy, Pourab; Beaver, Julia A; Pazdur, Richard; Kluetz, Paul G; Lemery, Steven J; Fashoyin-Aje, Lola A.

Afiliação

Horiba MN; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Casak SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Mishra-Kalyani PS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Roy P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Lemery SJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Fashoyin-Aje LA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

Clin Cancer Res ; 28(24): 5244-5248, 2022 12 15.

Article em En | MEDLINE | ID: mdl-35960160

Assuntos

Neoplasias Esofágicas; Nivolumabe; Adulto; Humanos; Adjuvantes Imunológicos/efeitos adversos; Protocolos de Quimioterapia Combinada Antineoplásica; Intervalo Livre de Doença; Neoplasias Esofágicas/tratamento farmacológico; Neoplasias Esofágicas/cirurgia; Junção Esofagogástrica/patologia; Neoplasia Residual/patologia; Nivolumabe/efeitos adversos; Intervalo Livre de Progressão; Ensaios Clínicos Controlados Aleatórios como Assunto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Nivolumabe Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google